SCHEMBL18735188

SCHEMBL18735188

CCN(CC)C(=O)C(CSC(=O)CC(=O)OC(C)C)NC(=O)C(C)C

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALOX15 P16050 1/20 0.32
▸ LMNA P02545 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735171 0.90 ALOX15 (0.33) ALOX15LMNA
SCHEMBL18735170 0.90 CNR2 (0.31) —
SCHEMBL18734960 0.88 — —
SCHEMBL18734936 0.88 ALOX15 (0.31) ALOX15
SCHEMBL18735159 0.87 MGAM (0.35) —
SCHEMBL18735180 0.87 ALOX15 (0.32) ALOX15LMNA
SCHEMBL18734939 0.82 — —
SCHEMBL18735053 0.82 CYP1A2 (0.38) ALOX15LMNA
SCHEMBL18735152 0.80 — —
SCHEMBL24454653 0.79 LMNA (0.37) ALOX15LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback